Seacoast Kidney and Hypertension Specialists — Portsmouth, New Hampshire

Seacoast Kidney and Hypertension Specialists is a clinical research site located in Portsmouth, New Hampshire, United States 03801.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Seacoast Kidney and Hypertension Specialists has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Kidney Disease, Chronic, Chronic Kidney Disease, End Stage Kidney Disease.

Sponsors: Boehringer Ingelheim, CSL Behring.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portsmouth

Browse all research sites in New Hampshire · View every site in Portsmouth

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Seacoast Kidney and Hypertension Specialists?

Seacoast Kidney and Hypertension Specialists has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Seacoast Kidney and Hypertension Specialists conducted?

Seacoast Kidney and Hypertension Specialists has 3 clinical trials on record, with 2 currently active. Their work covers Kidney Disease, Chronic, Chronic Kidney Disease, End Stage Kidney Disease.

Is Seacoast Kidney and Hypertension Specialists accredited by Crixeo Clinical Trials?

Seacoast Kidney and Hypertension Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Seacoast Kidney and Hypertension Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.